Sort by:

select Language:



WHO consolidated guidelines on drug-resistant tuberculosis treatment

World Health Organization WHO; Stop TB, (2019)


The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.
https://apps.who.int/iris/bitstream/handle/10665/3...


Choléra : Introduction

Organisation Mondiale de la Santé OMS, (2019)


Le choléra est une infection diarrhéique aiguë causée par l'ingestion d'eau ou d'aliments contaminés. Ce cours offre une introduction générale au choléra et s'adresse au personnel qui intervient en cas d'apparition de la maladie dans des situations d'urgence complexes ou dans des environnements où les infrastructures environnementales de base ont été endommagées ou détruites. Ce cours comprend des documents accessibles en anglais et en arabe. Nous espérons que ce cours vous aidera à vous rappeler de ce que vous savez déjà et à exécuter les bons principes de gestion du choléra. Objectif d'apprentissage : A la fin de ce cours, les participants devront être en mesure de : décrire la définition du cas et les alertes pour le choléra ; décrire les principales voies de transmission ; identifier les principales actions préventives ; et expliquer comment le contrôle du choléra est multisectoriel. Durée du cours : Environ 1 heure.
https://openwho.org/courses/cholera-introduction-f...


Doenças diarreicas agudas em emergências complexas

GRUPO MUNDIAL DE TRABALHO PARA CONTROLO DA CÓLERA, Eds.: OMS, (2010)


MEDIDAS VITAIS. Tomada de decisões para preparação e resposta.
http://whqlibdoc.who.int/hq/2004/WHO_CDS_CPE_ZFK_2...


Antiretroviral drug chart

NAM; AIDSMAP, (2019)


Version: 14 March 2019; A one-page reference guide to all the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions. The previous edition of the drugs chart is also available to download in Russian.
http://www.aidsmap.com/v636881573896370000/file/12...


Global influenza strategy 2019-2030

World Health Organization WHO, (2019)


The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic. The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect populations every year and helps prepare for a pandemic through strengthening routine programmes.
https://apps.who.int/iris/bitstream/handle/10665/3...


Management of Type 2 Diabetes. Training Manual

WHO Collaborating Centre for Capacity Building and Research in Community-based Noncommunicable Disease Prevention and Control, All India Institute of Medical Sciences (AIIMS), New Delhi, India. , Eds.: World Health Organization WHO, India, (2019)


WHO Package of Essential NCD Interventions (PEN) Accessed March 18,2019
https://www.who.int/diabetes/Diabetes-training-man...


Guidelines on second-and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus

World Health Organization WHO, (2018)


The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD Interventions (WHO PEN) for primary care in low-resources settings, reviewing several newer oral agents as second- and third-line treatment: dipeptidyl peptidase-4 inhibitors, sodium-glucose co-transporter 2 inhibitors and thiazolidinediones. The guidelines also present recommendations on the selection of type of insulin (analogue versus human insulin) for adults with type 1 and type 2 diabetes.
http://apps.who.int/iris/bitstream/handle/10665/27...


IDF Diabetes Atlas 2017

International Diabetes Federation IDF, (2018)


8th edition. Available in English, Spanish, French, Arabic , Chinese and Russian Large File. Please download directly from the website http://diabetesatlas.org/resources/2017-atlas.html An Interactive Version of the English, French and Spanish Version is available, too. Disponible en anglais, espagnol, français, arabe, chinois et russe Disponible en inglés, español, francés, árabe, chino y ruso Доступно на английском, испанском, французском, арабском, китайском и русском
http://diabetesatlas.org/resources/2017-atlas.html


Standards of Medical Care in Diabetes—2019Abridged for Primary Care Providers

American Diabetes Association, (2019)


Position Statement Diabetes Care2018;42(Suppl. 1):S1–S194.
http://clinical.diabetesjournals.org/content/diacl...


824 hits